![John Spencer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 27 $ al 31/07/2026
John Spencer is currently the Chief Financial Officer at Oragenics, Inc., a position held since 2026.
Education history includes undergraduate and graduate degrees from the University of South Florida.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 01/07/2026 | 53 ( 0 % ) | 27 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ORAGENICS, INC. | Director Financiero/CFO | 01/07/2026 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 2 |
|---|---|
Oragenics, Inc.
 Oragenics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel antibiotics and treatments against infectious disease and oral mucositis | Health Technology |
University of South Florida
 University of South Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
